Rankings
Pricing
Log In
Free Trial
US-listed companies
RedHill Biopharma Ltd.
Raw
RedHill Biopharma Ltd.
RDHL
Market cap
P/E ratio
Add to your list
Add to your list
Summary
Financials
Back to summarized table
B
M
K
USD
Annual
Quarterly
Download CSV
Dec 31,
2017
Dec 31,
2018
Dec 31,
2019
Dec 31,
2020
Dec 31,
2021
Dec 31,
2022
Dec 31,
2023
Dec 31,
2024
Cash and cash equivalents
16
29
29
29
29
20
6
5
Restricted cash
-
-
-
-
-
16
1
-
Trade receivables
2
1
1
29
32
35
3
3
Prepaid expenses and other receivables
3
2
2
6
5
4
3
1
Inventory
1
1
2
7
15
11
4
4
Total current assets
52
57
53
70
89
86
16
12
Restricted cash
-
-
-
16
16
0
0
0
Fixed assets
0
0
0
1
1
1
0
0
Right-of-use assets
-
-
4
5
4
7
1
0
Intangible assets
5
5
17
88
72
66
6
6
Total non-current assets
6
6
21
110
92
73
7
6
TOTAL ASSETS
57
62
74
180
181
159
23
18
Account payable
5
3
4
12
12
4
3
1
Current
-
-
1
2
2
1
1
0
Current refunds provision
-
-
-
-
-
-
-
9
Derivative financial instruments
-
-
-
-
-
-
-
1
Accrued expenses and other current liabilities
6
7
6
24
21
18
5
10
Total current liabilities
12
10
11
73
81
197
19
22
Lease liabilities
-
-
3
4
3
6
0
0
Royalty obligation
-
1
1
1
1
1
1
1
Total non-current liabilities
-
1
3
93
91
10
2
1
TOTAL LIABILITIES
12
11
14
166
172
207
21
23
Issued capital
1
1
1
1
1
3
21
35
Additional paid-in capital
-
-
-
-
-
-
-
375
Retained earnings
-133
-169
-208
-280
-368
-434
-408
-415
TOTAL EQUITY (CAPITAL DEFICIENCY)
45
51
60
14
9
-48
2
-5
TOTAL LIABILITIES AND EQUITY (CAPITAL DEFICIENCY)
57
62
74
180
181
159
23
18